BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Welcome MO, Mastorakis NE. Neuropathophysiology of coronavirus disease 2019: neuroinflammation and blood brain barrier disruption are critical pathophysiological processes that contribute to the clinical symptoms of SARS-CoV-2 infection. Inflammopharmacology 2021;29:939-63. [PMID: 33822324 DOI: 10.1007/s10787-021-00806-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 17.0] [Reference Citation Analysis]
Number Citing Articles
1 Batiha GE, Al-kuraishy HM, Al-gareeb AI, Alruwaili M, Alruwaili R, Albogami SM, Alorabi M, Saad HM, Simal-gandara J. Targeting of neuroinflammation by glibenclamide in Covid-19: old weapon from arsenal. Inflammopharmacol 2022. [DOI: 10.1007/s10787-022-01087-8] [Reference Citation Analysis]
2 Rossi E, Mutti L, Morrione A, Giordano A. Neuro–Immune Interactions in Severe COVID-19 Infection. Pathogens 2022;11:1256. [DOI: 10.3390/pathogens11111256] [Reference Citation Analysis]
3 Welcome MO, Kumar M D. Strategic Modeling of Medical Intelligence as a Countermeasure for Future Pandemics. MOLECULAR SCIENCES AND APPLICATIONS 2022;2:107-112. [DOI: 10.37394/232023.2022.2.12] [Reference Citation Analysis]
4 Pazdro-zastawny K, Dorobisz K, Misiak P, Kruk-krzemień A, Zatoński T. Vestibular disorders in patients after COVID-19 infection. Front Neurol 2022;13:956515. [DOI: 10.3389/fneur.2022.956515] [Reference Citation Analysis]
5 da Silva Júnior RT, Santos Apolonio J, Cuzzuol BR, da Costa BT, Silva CS, Araújo GRL, Silva Luz M, Marques HS, Santos LKS, Pinheiro SLR, Lima de Souza Gonçalves V, Calmon MS, Freire de Melo F. COVID-19 neuropsychiatric repercussions: Current evidence on the subject. World J Methodol 2022; 12(5): 365-380 [DOI: 10.5662/wjm.v12.i5.365] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Choi J, Park JH, Jo C, Kim K, Koh YH. SARS-CoV-2 spike S1 subunit protein-mediated increase of beta-secretase 1 (BACE1) impairs human brain vessel cells. Biochemical and Biophysical Research Communications 2022. [DOI: 10.1016/j.bbrc.2022.07.113] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Kuczborska K, Buda P, Książyk J. Long-COVID in immunocompromised children. Eur J Pediatr 2022. [PMID: 35834042 DOI: 10.1007/s00431-022-04561-1] [Reference Citation Analysis]
8 Kumar H, Gupta R. Neuroinvasion of Severe Acute Respiratory Syndrome Corona Virus-2 (SARS-CoV-2): Future Risk of Epilepsy. Int J Neurosci 2022;:1-17. [PMID: 35815479 DOI: 10.1080/00207454.2022.2100784] [Reference Citation Analysis]
9 Hamdy NM, Shaker FH, Zhan X, Basalious EB. Tangled quest of post-COVID-19 infection-caused neuropathology and what 3P nano-bio-medicine can solve? EPMA J 2022;:1-24. [PMID: 35668839 DOI: 10.1007/s13167-022-00285-2] [Reference Citation Analysis]
10 Chiang W, Stout A, Yanchik-slade F, Li H, Nilsson B, Gelbard H, Krauss T. A Quantum Dot Biomimetic for SARS-CoV-2 to Interrogate Dysregulation of the Neurovascular Unit Relevant to Brain Inflammation.. [DOI: 10.1101/2022.04.20.488933] [Reference Citation Analysis]
11 Kaliyappan K, Chen Y, Krishnan Muthaiah VP. Vestibular Cochlear Manifestations in COVID-19 Cases. Front Neurol 2022;13:850337. [DOI: 10.3389/fneur.2022.850337] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
12 Szczepanska-Sadowska E, Wsol A, Cudnoch-Jedrzejewska A, Czarzasta K, Żera T. Multiple Aspects of Inappropriate Action of Renin-Angiotensin, Vasopressin, and Oxytocin Systems in Neuropsychiatric and Neurodegenerative Diseases. J Clin Med 2022;11:908. [PMID: 35207180 DOI: 10.3390/jcm11040908] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
13 Theoharides TC. Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome? Mol Neurobiol 2022. [PMID: 35028901 DOI: 10.1007/s12035-021-02696-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 19.0] [Reference Citation Analysis]
14 Krey L, Huber MK, Höglinger GU, Wegner F. Can SARS-CoV-2 Infection Lead to Neurodegeneration and Parkinson's Disease? Brain Sci 2021;11:1654. [PMID: 34942956 DOI: 10.3390/brainsci11121654] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
15 Lamontagne SJ, Winters MF, Pizzagalli DA, Olmstead MC. Post-acute sequelae of COVID-19: Evidence of mood & cognitive impairment. Brain Behav Immun Health 2021;17:100347. [PMID: 34549199 DOI: 10.1016/j.bbih.2021.100347] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 19.0] [Reference Citation Analysis]
16 Valeri A, Chiricosta L, Calcaterra V, Biasin M, Cappelletti G, Carelli S, Zuccotti GV, Bramanti P, Pelizzo G, Mazzon E, Gugliandolo A. Transcriptomic Analysis of HCN-2 Cells Suggests Connection among Oxidative Stress, Senescence, and Neuron Death after SARS-CoV-2 Infection. Cells 2021;10:2189. [PMID: 34571838 DOI: 10.3390/cells10092189] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
17 Alipoor SD, Mortaz E, Varahram M, Garssen J, Adcock IM. The Immunopathogenesis of Neuroinvasive Lesions of SARS-CoV-2 Infection in COVID-19 Patients. Front Neurol 2021;12:697079. [PMID: 34393976 DOI: 10.3389/fneur.2021.697079] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
18 Joshi C, Jadeja V, Zhou H. Molecular Mechanisms of Palmitic Acid Augmentation in COVID-19 Pathologies. Int J Mol Sci 2021;22:7127. [PMID: 34281182 DOI: 10.3390/ijms22137127] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
19 Moro E, Taba P. COVID-19: An unforgettable challenge for the neurology community. Eur J Neurol 2021. [PMID: 34033184 DOI: 10.1111/ene.14937] [Reference Citation Analysis]